Litcius/Paper detail

SO-26 Clinical efficacy of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients

Ryan B. Corcoran, Marios Giannakis, Jill N. Allen, J. Chen, Karin Pelka, Serena H. Chao, Jeffrey A. Meyerhardt, Andrea C. Enzinger, Peter C. Enzinger, Nadine J. McCleary, M. Yugelun, Thomas A. Abrams, Katie Kanter, Emily Van Seventer, William B. Bradford, Isobel J. Fetter, Giulia Siravegna, Jinwei Tian, Jeffrey W. Clark, David P. Ryan, Nir Hacohen, Aparna R. Parikh

2020Annals of Oncology43 citationsDOIOpen Access PDF

Topics & Concepts

MedicineColorectal cancerOncologyInternal medicineCancer researchMEK inhibitorCancerKinaseMAPK/ERK pathwayGeneticsBiologyColorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsColorectal and Anal Carcinomas
SO-26 Clinical efficacy of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients | Litcius